IRIS
MARRELLI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.363
EU - Europa 16.962
AS - Asia 3.058
AF - Africa 120
SA - Sud America 61
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 17
Totale 38.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.320
GB - Regno Unito 4.954
IE - Irlanda 3.107
CN - Cina 2.072
UA - Ucraina 1.744
IT - Italia 1.701
SE - Svezia 1.508
RU - Federazione Russa 1.188
FR - Francia 985
DE - Germania 838
SG - Singapore 628
FI - Finlandia 479
ES - Italia 135
VN - Vietnam 99
BE - Belgio 88
CI - Costa d'Avorio 68
IN - India 52
IR - Iran 40
CA - Canada 35
RO - Romania 35
TR - Turchia 33
NL - Olanda 32
BR - Brasile 28
AU - Australia 26
MU - Mauritius 26
PT - Portogallo 25
CZ - Repubblica Ceca 22
EG - Egitto 19
PL - Polonia 19
JP - Giappone 17
KR - Corea 17
EU - Europa 16
CH - Svizzera 12
PH - Filippine 11
AT - Austria 10
GR - Grecia 10
SA - Arabia Saudita 10
CL - Cile 9
KG - Kirghizistan 9
BG - Bulgaria 8
HK - Hong Kong 8
SI - Slovenia 8
AR - Argentina 7
AZ - Azerbaigian 7
LV - Lettonia 7
DK - Danimarca 6
EC - Ecuador 6
ID - Indonesia 6
KZ - Kazakistan 6
LU - Lussemburgo 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
AL - Albania 4
BD - Bangladesh 4
EE - Estonia 4
ET - Etiopia 4
IL - Israele 4
LT - Lituania 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PE - Perù 4
PK - Pakistan 4
RS - Serbia 4
AM - Armenia 3
HU - Ungheria 3
NO - Norvegia 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
BO - Bolivia 2
CY - Cipro 2
IM - Isola di Man 2
IQ - Iraq 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
LK - Sri Lanka 2
MX - Messico 2
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
CM - Camerun 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
MA - Marocco 1
MC - Monaco 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 38.611
Salva come PNG Salva come JPEG
Città #
Southend 4.666
Fairfield 3.121
Dublin 3.081
Chandler 1.612
Jacksonville 1.508
Ashburn 1.430
Woodbridge 1.370
Wilmington 1.175
Seattle 1.118
Houston 1.078
Cambridge 989
Ann Arbor 780
Princeton 575
Nanjing 473
Singapore 424
Beijing 379
Siena 370
Boardman 230
San Mateo 226
Helsinki 190
New York 187
Shanghai 163
San Diego 161
Nanchang 138
Shenyang 137
Málaga 125
Moscow 120
Dong Ket 89
Hebei 89
Tianjin 86
Florence 84
Brussels 83
Abidjan 68
Jiaxing 66
Changsha 65
Düsseldorf 65
Kunming 60
Rome 57
Munich 52
Jinan 50
London 50
Milan 50
Dearborn 49
Menlo Park 48
Norwalk 46
Venezia 46
Ningbo 44
Los Angeles 33
San Francisco 33
Zhengzhou 33
Falls Church 32
Guangzhou 32
Dallas 31
Washington 31
Höst 28
Hangzhou 27
Port Louis 26
Redwood City 21
Santa Clara 21
Fremont 20
Taizhou 20
Tappahannock 20
Toronto 20
Changchun 17
Frankfurt am Main 17
Naples 16
Brno 15
Lappeenranta 15
Serra 15
Izmir 14
Porto 14
Andover 13
Genoa 13
Livorno 13
Verona 13
Zanjan 13
Bologna 12
Hounslow 12
Indiana 12
Kilburn 12
Lanzhou 10
Leawood 10
Mestre 10
Phoenix 10
Riyadh 10
Sacramento 10
Tehran 10
Tokyo 10
Vienna 10
Bishkek 9
Canberra 9
Chicago 9
Palermo 9
Redmond 9
Turin 9
Viareggio 9
Arezzo 8
Berlin 8
Fuzhou 8
Lisbon 8
Totale 27.922
Salva come PNG Salva come JPEG
Nome #
Patologie del duodeno 460
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study 226
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) 205
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 202
C-Met targeting in advanced gastric cancer: An open challenge 201
354. KRAS mutation in gastric cancer- molecular, and clinico-pathological characteristic 193
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases 188
Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: An observational study on outcome and microcirculatory changes 188
Familial aggregation of gastric cancer with microsatellite instability** 186
65. Molecular surgery for gastric cancer-role of microsatellite instability in elderly patients 183
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 182
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 180
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 178
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 174
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 173
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 173
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 173
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses 173
611. Gastric cancer patients with familial aggregation of gastric cancer and Lynch syndrome associated cancers with microsatellite instability 172
Recurrence after surgery in esophago-gastric junction adenocarcinoma: Current management and future perspectives 172
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 172
613. Lymph node metastases in microsatellite unstable gastric cancer 171
612. Molecular background of high risk and low risk areas of gastric cancer in Italy 171
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives 171
610. Heterogeneity of new molecular gastric cancer classifications. Clinico-pathological characteristic 169
353. PIK3CA mutation in gastric cancer and the role of different codon mutations in the new molecular division of that neoplasm 168
Clinical evaluation of the Mannheim Prognostic Index in post-operative peritonitis: a prospective cohort study 168
Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases 167
From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model 167
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. 166
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer 166
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial 165
Il ruolo della chemioipertermia nel carcinoma del colon-retto 164
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study 164
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 164
530. Minimally invasive surgery for the treatment of colo-rectal adenocarcinoma: Laparoscopic and robotic approach 164
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 162
The pattern of lymph node metastases in microsatellite unstable gastric cancer 161
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer 161
Trattamento chirurgico radicale di emangiopericitoma retroperitoneale recidivo: case report. 161
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an italian family 160
Clinical impact of molecular classifications in gastric cancer 159
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data 159
Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection? 157
CA 19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions 157
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables 155
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 155
Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study 155
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 155
Gastric stump carcinoma after distal subtotal gastrectomy for early gastric cancer: Experience of 541 patients with long-term follow-up 155
Is sleeve gastrectomy a therapeutic procedure for all obese patients? 154
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the “Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network” (SICO-CCN) multicentre collaborative study 154
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 154
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 153
Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes 151
External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study 151
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 150
E-cadherin and hereditary diffuse gastric cancer. 149
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience 149
Complications after surgery for gastric cancer in patients aged 80 years and over 149
Robotic single docking total colectomy for ulcerative colitis: First experience with a novel technique 148
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 147
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 146
Accuracy of MDCT in the Preoperative Definition of Peritoneal Cancer Index (PCI) in Patients with Advanced Ovarian Cancer Who Underwent Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 146
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence 146
International consensus on a complications list after gastrectomy for cancer 146
K-RAS mutation in gastric cancer and its link with microsatellite instability status 146
Elastofibroma dorsi: three cases of personal experience 145
Primary non-Hodgkin's breast lymphoma: surgical approach. 145
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 145
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer 144
Western perspective and epidemiology of gastric cancer 144
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer 144
null 144
A rare case of primary small bowel adenocarcinoma with intussusception. 143
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 143
Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. 143
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 142
A clinical case of duodenal gastrointestinal stromal tumor with a peculiarity in the surgical approach. 142
High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. 142
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer 142
Super-extended (D3) lymphadenectomy in advanced gastric cancer. 141
Gastro-pleuro-pericardial fistula following combined radiation and chemotherapy for lung metastases from renal cell carcinoma: report of a case 141
High incidence of familial gastric cancer in Tuscany, a region in Italy. 141
Factors influencing survival after hepatectomy for metastases from gastric cancer 140
An aggressive early gastric cancer: Kodama's PenA type 140
Accuracy of MDCT in preoperative definition of maximum tumour diameter in patients with gastric cancer 140
Histological variety of gastric carcinoma and Helicobacter pylori cagA and vacA polymorphism 140
Gastric stump cancer after distal gastrectomy for benign disease: Clinicopathological features and surgical outcomes 139
Evidence of tumor microsatellite instability in gastric cancer with familial aggregation 139
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 139
Presacral ganglioneuroma: a case report and review of literature 138
Complications after gastrectomy for cancer: Italian perspective 138
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience 137
A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. 137
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 137
Gastric cancer: Current status of lymph node dissection 137
The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients 137
Age Related Co-Morbidities in Colorectal Cancer Patients: Surgical Problems and Prognostic Impact 137
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 136
Totale 16.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.054 0 0 0 0 472 596 661 1.056 720 706 314 529
2020/20215.894 226 728 176 641 249 654 234 903 703 464 487 429
2021/20224.288 375 532 279 293 218 167 208 147 224 463 477 905
2022/20236.027 352 384 815 860 587 1.320 146 465 601 177 171 149
2023/20244.563 220 133 373 163 149 1.211 1.676 82 24 161 59 312
2024/20252.351 313 517 794 482 245 0 0 0 0 0 0 0
Totale 39.090